Page 1 of Clinical Trials for Vidaza, 212 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Phase I 5-Azacytidine Plus VPA Plus ATRA
Last Updated: April 10, 2012
Condition(s): Myelodysplastic Syndrome; Acute Myelogenous Leukemia
2
Recruiting
VIDAZA-DLI Pre-emptive Azacitidine and Donor Lymphocyte Infusions Following Allogeneic Hematopoietic Stem Cell Transplantation for High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
Last Updated: March 26, 2012
Condition(s): Acute Myeloid Leukemia; Myelodysplastic Syndrome
3
Active, not recruiting
5-Azacytidine (Azacytidine; Vidaza) in Chronic Lymphocytic Leukemia
Last Updated: September 2, 2011
Condition(s): Chronic Lymphocytic Leukemia; Leukemia
4
Not yet recruiting
Azacitidine With or Without Ceplene/Interleukin-2 in Patients With Higher Risk Myelodysplastic Syndromes
Last Updated: March 28, 2011
Condition(s): Myelodysplastic Syndromes
5
Not yet recruiting
Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML)
Last Updated: April 2, 2012
Condition(s): Leukemia
6
Active, not recruiting
Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck Cancer
Last Updated: October 5, 2011
Condition(s): Non-small Cell Lung Cancer; Squamous Cell Carcinoma of the Head and Neck
7
Terminated
Phase 2 Study of Azacitidine (Vidaza) vs MGCD0103 vs Combination in Elderly Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Last Updated: April 28, 2011
Condition(s): Acute Myeloid Leukemia (AML); Myelodysplastic Syndrome (MDS)
8
Recruiting
Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine
Last Updated: October 13, 2011
Condition(s): Acute Myeloid Leukemia (AML)
9
Recruiting
The Efficacy of Azacitidine +/- Lenalidomide in High-risk Myelodysplastic Syndrome (MDS)and Acute Myeloid Leukemia (AML) With Del(5q).
Last Updated: March 14, 2012
Condition(s): Myelodysplastic Syndrome; Acute Myelogenous Leukemia
10
Recruiting
Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) in Combination With Azacitidine for the Treatment of Myelodysplastic Syndrome (MDS)
Last Updated: October 6, 2011
Condition(s): Myelodysplastic Syndromes
11
Completed
Phase I/II 5-Azacytidine Plus VPA Plus ATRA
Last Updated: June 6, 2011
Condition(s): Myelodysplastic Syndrome; Acute Myelogenous Leukemia
12
Recruiting
Azacitidine and CAPOX in Metastatic Colorectal Cancer
Last Updated: March 1, 2012
Condition(s): Colorectal Cancer
13
Recruiting
Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma
Last Updated: November 21, 2011
Condition(s): Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Hepatosplenic T-cell Lymphoma; Peripheral T-cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Prolymphocytic Leukemia; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Small Intestine Lymphoma; T-cell Large Granular Lymphocyte Leukemia
14
Recruiting
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
Last Updated: March 29, 2012
Condition(s): MDS; AML; Solid Tumors; Multiple Myeloma; Non-Hodgkin's Lymphoma; Hodgkin's Disease
15
Recruiting
A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia
Last Updated: January 17, 2012
Condition(s): Chronic Myelomonocytic Leukemia
16
Recruiting
A Study Being Conducted at Multiple Locations to Compare the Safety and Effectiveness of Three Different Treatment Regimens; 1) Lenalidomide, 2) Lenalidomide + Azacitidine, or 3) Azacitidine Alone in Newly Diagnosed Acute Myeloid Leukemia Subjects ≥ 65 Years of Age
Last Updated: May 1, 2012
Condition(s): Acute Myeloid Leukemia; Acute Myelogenous Leukemia
17
Recruiting
A Phase I/II Clinical Trial of Vidaza With Abraxane in the Treatment of Patients With Advanced or Metastatic Solid Tumors and Breast Cancer
Last Updated: August 5, 2011
Condition(s): Advanced or Metastatic Solid Tumors; Advanced or Metastatic Breast Cancer
18
Recruiting
Azacitidine and Lenalidomide for Acute Myeloid Leukemia
Last Updated: October 6, 2011
Condition(s): Leukemia, Myeloid, Acute
19
Recruiting
Intensified Azacitidine in High Risk Myelodysplastic Syndrome (MDS)
Last Updated: December 12, 2011
Condition(s): Myelodysplastic Syndrome
20
Suspended
Azacitidine and MS-275 in Treating Patients With Recurrent Advanced Non-Small Cell Lung Cancer
Last Updated: April 27, 2012
Condition(s): Lung Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Vidaza

Page 1 of Clinical Trials for Vidaza, 212 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About